135.30 3.30 (2.50%)
NSESep 25, 2020 03:31 PM
There are 1 reports from 1 analysts covering Mangalam Drugs and Organics Ltd. available on trendlyne.com.
|Summary||Date||Stock||Broker||Price at Reco.||Target||Price at reco|
Change since reco(%)
|2019-11-05||Mangalam Drugs and O..||ICICI Securities Limited||35.85||35.85 (277.41%)||Sell|
ICICI Securities Limited
Mangalam Drugs & Organics (Mangalam) is one of the largest and most preferred API suppliers for anti-malarial drug manufacturing companies in India and abroad. It is one of the five companies globally to qualify under the Bill Clinton Foundation for supply of anti-malarial drugs. The company's APIs are largely supplied to companies, which participate in WHO tenders and are funded by various global agencies like Clinton Foundation, Gates...
|2017-04-19||Mangalam Drugs and O..||ICICI Securities Limited||170.10||225.00||170.10 (-20.46%)||Target met||Buy|